Efficacy and Safety of Two Atypical Antipsychotics vs. Placebo in Patients With an Acute Exacerbation of Either Schizophrenia or Schizoaffective Disorder
Conditions
- Schizophrenia
- Schizoaffective Disorder
Interventions
- DRUG: risperidone, quetiapine
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Collaborators